“Executive Summary: The global acute intermittent porphyria market size was valued at USD 4.60 billion in 2024 and is expected to reach USD 7.28 billion by 2032, at a CAGR of 5.9% during the forecast period This growth is driven by factors such as the advancements in diagnostic ...